People · Operator
Named in public records as an officer, director or promoter · active 2014–2022 · Biotech / Pharma, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Next Frontier Biosciences, LLC | — | Biotech / Pharma | Seed | $8.7M | $34.0M | 2014 |
| Rythera Therapeutics Inc. | — | Biotechnology | Seed | $1.3M | $21.8M | 2022 |
Marc Graboyes at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Marc Graboyes on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Johnson | 1 | 11 |
| Paul Johnson | 1 | 10 |
| Stephen Hoffman | 1 | 7 |
| Charles Sander | 1 | 3 |
| Reginald Hardy | 1 | 2 |
| Rhonda Bhagwandeen | 1 | 1 |
| Dan Browne | 1 | 1 |
| James Kreitman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.